chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She got her vaccine and about an hour later she started coughing, sneezing.  She called the pharmacy and they said there was no information on the vaccine yet.  She then started using a box of tissues a day due to blowing her nose so much, running a high fever as her top lip blistered up and had a raw nose from all the blowing.  She had pains running down both sides of her neck to her shoulders.  This went on for about a week.  Her best kept trying to call her, she did not answer the phone.  She could not hear the phone ringing next to her as a friend was trying to get a hold of her.   Her friend called her son and he told her she had to go to the hospital  Her BP 85/42 and was given two prescription.  She was negative for COVID and the flu even though she had the symptoms of the flu.  She wasn't getting better so she called her PCP who called her in Amoxicillin which she has been on for a week.  She has to Friday to finish it.  She is almost 100% completely.  She forced herself to get up after she went home from the ER, and gradually started improving.
My kidneys began bleeding a little less than 24 hours after my second dose of the COVID-19 vaccine. I realized this because I had a large amount of blood in my urine. My particular kidney disease will cause my antibodies to fight my kidneys when I am sick and I will urinate blood. The second shot caused this to happen and I have been urinating blood for over 24 hours. 3 days is typical when I have an occurrence. I haven't had one of these occurrences in over a year or 2.
This spontaneous report as received from a health professional refers to a 4 year old patient. On 07-MAY-2014 the patient was vaccinated with (Oka/Merck) VARIVAX (lot # J002319. expiration date 22-FEB-2014, dose and route not reported) and M-M-R II (Lot # J003785, expiration date 28-MAR-2015, dose and route not reported) which were stored improperly. There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information is not expected.
24JAN97 started w/vesicles;scabbed the next day;itchy;27JAN97 presented in office w/ 3 scabbed lesions on the back, 2 scabbed lesions on the forehead & 1 small pink papules on forehead;no fever;no cough;exposed to vaccine 2wk prior
Feeling of throat closing up, shortness of breath, some nausea.  Given dexamethasone 10mg IM and was feeling much better at 45 minutes.
My husband tested positive while he was in the hospital. I was around him and I was having a stuffy nose and headache. I was lethargic and I thought maybe I should test as well as I was feeling very lousy. That test was positive and so I called my Doctor and I got Paxlovid and I started taking the medication that day. The medication helped and I was feeling much better and had finished the medication. I did take another test and I tested negative for COVID-19. By the 29th and the 30th I was sneezing and my nose was running again. I tested again that Thursday and it was positive for COVID-19 again. I called my doctor back and let them know I was positive again after being negative. I was given Paxlovid again and have two days left at this point. I have been sneezing so much and for some reason that is the worst symptom I am having. I tested again last night and the test was positive but it was very very faint. I am recovering though and will take the last two days of my Paxlovid tomorrow.
RECEIVED FLU SHOT AT 1300 ON 10/26/2011.  REPORTS DRY "BEET RED" EYES, DRY COUGH, TEMP OF 99.8, WHEEZING "NOT BAD" BODY ACHES.  DID NOT REPORT TO PHYSICIAN, CLINIC OR ER.  TOOK IBUPROFEN AND SYMPTOMS LASTED ABOUT 12 HOURS.
Patient couldn't move her arm up, down or sideways. It hurt from around 5:00pm after getting the shot and got worse for 24 hours +. She was in agony and couldn't put her seat belt on in the car and cried through the first night. For the next 24 hours, she was on ADVIL and ice packs. This is Tuesday and she is now just lifting her arm, but not comfortably. The Vaccine was from Glaxo-Smith Kline: Dosage 0.5ml.
A 26 year old female patient (CR) experienced rash, pruritus and swelling of the entire body after prophylactic vaccination with RabAvert. The patient received Imovax on 08/19/04 and 08/26/04; on 09/11/04 she received 1 ml of RabAvert intramuscularly in the left deltoid. Concomitant medication remained unspecified. The medical history included a local response to fire ants bites (ankle was swollen and sore); the patient had no known allergies. Three hours after receiving RabAvert she experienced rash, itching and swelling all over her body. On 09/14/04 the patient reported the reaction and was seen by both an occupational health doctor and an allergist. The reaction had localized to involve only the neck, and she was treated with Allerga and triamcinolone cream. On 09/17/04 she was reassessed. The treating physican felt the reaction was due to an allergic reaction to an acacia tree, not RabAvert, and found that events were completely resolved.
Student broke out after receiving vaccine at school. She did not return to the Health Center that afternoon but came in the next morning. Student presented w/ raised, red rash to (L) upper arm. (L) upper chest, and (L) ankle. (+) pruritis.
Onset of tingling, slight numbness on right side of face and tongue about 20 minutes after injection. Outcome: lasting about 2 hours and gradually diminishing.
A company representative reported that a 7 year old male received Prevnar in April, 2000. The child, subsequently, developed swelling at the site of the Prevnar injection that extended from his shoulder to his elbow. The child was treated with diphenhydramine and recovered.
Around 9 pm, my arm became more sore and started radiating into my shoulder and I had chills.  I had a low-grade fever and I had slight SOB. Not sure if it was due to vaccine or the fact that I'm big and pregnant. The next more I was extremely sore all over. I also experienced major fatigue and a headache. I just rested and felt better afterwards and it went away.
This spontaneous report as received from a physician via a company representative refers to an unspecified number of patients (reported as "a couple of patients") of unknown age and gender. On an unknown date the patients were vaccinated with a dose of GARDASIL (dose, route and lot number not reported). On an unknown date the patients passed out after receipt of GARDASIL. The outcome of the event and relatedness between the event and GARDASIL were not reported. Upon internal review the event of passing out was determined to be medically significant. Additional information has been requested.
The date when the vial was stored in the fridge was 14-Mar-2023 and the date of administration was 21-Apr-2023; No adverse event; Inadvertently administered 9 doses of the bivalent vaccines to patients from 5 vials which were beyond the BUD; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Inadvertently administered 9 doses of the bivalent vaccines to patients from 5 vials which were beyond the BUD), PRODUCT STORAGE ERROR (The date when the vial was stored in the fridge was 14-Mar-2023 and the date of administration was 21-Apr-2023) and NO ADVERSE EVENT (No adverse event) in an 81-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch nos. 066H22A and 060F22A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 23-Dec-2022, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 21-Apr-2023, received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) dosage was changed to 1 dosage form. On 21-Apr-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Inadvertently administered 9 doses of the bivalent vaccines to patients from 5 vials which were beyond the BUD). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The date when the vial was stored in the fridge was 14-Mar-2023 and the date of administration was 21-Apr-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Inadvertently administered 9 doses of the bivalent vaccines to patients from 5 vials which were beyond the BUD), PRODUCT STORAGE ERROR (The date when the vial was stored in the fridge was 14-Mar-2023 and the date of administration was 21-Apr-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Inadvertently administered 9 doses of the bivalent vaccines to patients from 5 vials which were beyond the BUD) and PRODUCT STORAGE ERROR (The date when the vial was stored in the fridge was 14-Mar-2023 and the date of administration was 21-Apr-2023).    No concomitant medications were reported.  No adverse event was reported and a dose of the Moderna vaccine was given to the patient beyond the use by date of 13-Apr-2023.  The dose details of the fourth and third doses of Moderna vaccine was reported as 0.5.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-721275 (E2B Linked Report). This case was linked to MOD-2023-722267 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-721275:master case
Case number PHEH2014US02276, is an initial spontaneous report received from a nurse on 03 Nov 2014. This report refers to a patient of unknown identifiers. The patient's medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1413901) on an unspecified date. It was reported that FLUVIRIN was stored in the refrigerator at an appropriate temperature and when the reporter pulled the vaccine out it had a frothy and bubble look. It was also reported that reporter was not sure that while patient was being vaccinated, the vaccine was frothy or not. Patient was fine. No adverse events reported after the maladministration.
This spontaneous report was received from a Certified Medical Assistant referring to an adult patient of unknown gender. The patient's concurrent conditions and medical history were not provided. There was no concomitant medication reported. The health care worker reported that on an unknown date the "adult patient" needed to have titers taken post vaccination. Therefore, vaccine with M-M-R II was ordered and patient was vaccinated with M-M-R II (dose, route, lot number and expiration date were not reported) for prophylaxis. On an unspecified date, provider thought there was no response so had titers for measles, mumps and rubella on patient "but response to titers might have been too early". At the reporting time the outcome of therapy non-responder was unknown. It was also reported that there were no adverse effects.
Sore arm; This is a spontaneous report from a contactable consumer (patient, reported for self). A 54-year-old (non-pregnant) female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number and expiry date: unknown), dose 2 via an unspecified route of administration, administered in left arm on an unspecified date as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was not pregnant at the time of vaccination. The patient had earlier received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: Not reported) via via an unspecified route of administration, administered in left arm (reported as) on 31Jan2021 at 12:00 (at the age of 54-years-old) for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. On 20Feb2021 13:30, the patient experienced sore arm. Felt as if punched in the arm. Even hurt when not using arm. By 22Feb, arm only hurt when using it. Much less sore. Patient received no treatment for the event. Post vaccination, the patient was not tested for COVID-19. The outcome of event was recovering.   Follow-up attempts completed. No further information expected.
Vaccine administration error related to temperature excursion from recommended storage temperature, not known to this writer to be associated with an adverse event. The local clinic has relayed to this writer that prior to the vaccine's thawing and administration to the vaccine recipient, the administered vaccine was stored in frozen temperatures for longer than recommended by the manufacturer.
got extremely sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient. A female patient received bnt162b2 (BNT162B2), administration date 12Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious) with onset Feb2021, outcome "recovered" (2021), described as "got extremely sick". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: It was reported that, caller got her 1st dose on 12Feb2021 and within 24 hours she got extremely sick and was sick for 3 weeks. They told her to not get the 2nd dose and instead do a anit-body test. She did an antibody test and it came back negative. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Administration of shot was painful. 2 hours after shot, felt faint, nausea, and arm was very sore. Immediately needed to lay down. Arm became so sore I couldn't move it at all.  Went to bed and slept for 23 hours with chills and sweats. Low (100) fever 23 hours later and very painful arm.  Symptoms gradually decreased over the next 24 hours, total of 48 hours.
Pt previously experience Guillain Barre Syndrome at earlier age. Pt reports same symptoms appeared 1wk after rec. MMR vaccine.
Arm soreness, fever, chills, headache, soreness of entire body, nasal congestion, and sore throat.
PATIENT CALLED ON 2/14/18 AROUND 10 AM TO REPORT THAT A FEW HOURS AFTER RECEIVING HER FIRST DOSE OF SHINGRIX VACCINE SHE HAD A FEVER, SHAKES AND HEADACHE. SHE TOOK TYLENOL TO RELIEVE SOME OF SYMPTOMS BUT FEVER STILL AROUND 100 DEGREES F, THIS MORNING.
This spontaneous report was received from a healthcare professional refers to a patient of unknown age. On 11-JUN-2013, the patient was vaccinated with a dose of ROTATEQ, (lot # H011439, expiry date 01-DEC-2013, route was not reported) which may have been improperly stored at 8.5 degrees celsius to 9.1 degrees celsius for 720 hours. No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Experienced low grade fever, chills, and joint pain starting 5 days after injection.  Had no symptoms, other than a sore arm, for the first few days after injection.
pt awakened w/fever, shakey, dizzy, h/a, jerky movement of legs; 9 hrs (3AM) p/vax given; APAP given;
Myelitis transverse; Paralyzed; her knees down to her feet into her toes stayed on fire now; This is a spontaneous report from contactable nurse (patient). A 75-year-old female patient received the 2nd dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), intramuscular administered in arm right on 06Feb2021 10:10 (Lot Number: EL9264) as DOSE 2, SINGLE for COVID-19 immunisation. Medical history included spinal operation from in Jan2020 (not ongoing). The patient's concomitant medications were not reported. Previously the patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech) (Lot# 2L3302) on 05Jan2021 at 75 years for COVID-19 immunisation with no adverse effect. In Mar2021 or Apr2021 the patient became paralyzed. The event caused patient's hospitalization for 2 days and they did MRI and CT scan. Both tests came out normal. She was told her spinal cord was wide open and hardware looked good. The event also required emergency room visit and physician office visit (neurologist). On 27Jul2021 she saw the neurologist which diagnosed her with transverse myelitis with outcome of unknown. She could walk now, she was diagnosed transverse myelitis from the vaccine. Treatment included physical therapy. She reported that below her knees down to her feet into her toes stayed on fire in Aug2021 with outcome of not recovered, and she had testing done another MRI. She also had a test in Aug2021 on her muscles and nerves, she does not know the name of the test.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship,  a possible causal relationship between the events Transverse myelitis, Paralysis and suspect drug BNT162B2 cannot be excluded.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
What led me to the COVID-19 test was feeling feverish, not quite right. At that point I was heaving. At some point, I took the test on 01/08 and I had COVID-19. In one of my visits to my PCP, during these episodes, it was determined I had a sinus infection along with COVID-19. I was prescribed an antibiotic. It helped with my sinuses and it felt great and the symptoms of COVID-19 went away over time. I had this hack that I couldn't get rid of and my heart rate was elevated at 130 BPM. I went to the ER 02/17/2023 and I had tests done and it was determined I had walking pneumonia. I was prescribed erythromycin and penicillin. I was done with those meds by 02/28/2023. I'm not sure what the real order was of these events, but I was sick for about 2 months and finally recovered by the end of February. I would say that was the sickest I had ever felt in my life.
general aches / pain; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain. On an unknown date, the outcome of the pain was not reported.   It was unknown if the reporter considered the pain to be related to Shingrix.  Additional details were provided as follows: The age at the vaccination was not reported. The age group was not reported but was selected as an adult as per the vaccine indication. The patient experienced general aches .  The patient asked to take a nonsteroidal pain medication.
PATIENT STATES IS DIZZY AND HAVING A HARD TIME BREATHING. PATIENT O2 SAT IS 99% WITH A PULSE OF 96. PATIENTS SYMPTOMS RESOLVED AND RELEASED. PATIENT INSTRUCTED TO FOLLOW-UP WITH EMERGENCY ROOM IF SYMPTOMS STARTED BACK.
Patient was unresponsive for approximately 2 minutes. Stated feeling dizzy. EMS arrived and checked patient over.  She refused going to hospital.
Gastritis with potential peptic ulcers. Began with severe heartburn and stomach pain the day after vaccination. Went to two emergency rooms, a visit with primary care provider, underwent blood testing (inconclusive), H. Pylori breath testing (negative),  and am scheduled for an upper endoscopy, HIDA scan, and GI visit.
9/24/21 @ 6pm: itchy painful hives on torso and neck; 9/25/21 @ 3pm: itchy hives on torso, neck and arms
Narrative:  75yo male patient died at home on 1/4/2021,cause of death unknown. See pt's problem list below: PROBLEM LAST MOD PROVIDER Prolonged grief disorder (SCT 723914003) 12/21/2021 (ICD-10-CM F43.20) Hypothyroidism (SCT 40930008) (ICD-10-CM E03.9) 11/02/2021 11/21 Depressive disorder (SCT 35489007) (ICD-10-CM 06/28/2021 F32.9) Thrombocytopenia (SCT 302215000) (ICD-10-CM 05/27/2021 D69.6) MR - Mitral regurgitation (SCT 48724000) 05/21/2021 (ICD-10-CM I34.0) Mod/severe per ECHO 05/21 TR - Tricuspid regurgitation (SCT 111287006) 05/21/2021 (ICD-10-CM I07.1) Mod/severe per ECHO 05/21 Diastolic dysfunction (SCT 3545003) (ICD-10-CM 05/21/2021 R69.) Grade III per ECHO 12/19, not mentioned per ECHO 05/21 Tubular adenoma of colon (SCT 444898006) 05/21/2021 (ICD-10-CM D12.6) C-scope 10/22/19: cecum , asc, hep flexure, disc Atrial fibrillation (SCT 49436004) (ICD-10-CM 05/21/2021 I48.91) 1. S/p pacemaker and AICD 2. Fail cardioversion 08/13/19 Chronic systolic heart failure (SCT 441481004) 05/21/2021 (ICD-10-CM I50.22) EF 35 5 and asynchronous LV motion per ECHO 05/17/21 Full care by hospice (SCT 170935008) (ICD-10-CM 05/21/2021 R69.), Onset 12/19/2019 1. Heart Failure 2. ICD was deactivated upon admission to Hospice and reactivated after discharge from Hospice on 10/16/20 cardiology clinic visit Seen by palliative care service (SCT 441874000) 05/21/2021 (ICD-10-CM Z51.5) Admitted and later discharged from Hospice care Arrested development following protein-calorie 11/24/2015 malnutrition (SCT 74257000) (ICD-10-CM Z43.1) Gastritis (SCT 4556007) (ICD-10-CM K29.70) 05/21/2021 EGD 10/19, mild (ICD-10-CM I47.2); Ventricular tachycardia 12/04/2015 (SNOMED CT 25569003) Pulmonary embolism (SCT 59282003) (ICD-10-CM 05/21/2021 I26.99) 10/12 R subsegmental artery (ICD-9-CM 306.9); Somatization (ICD-9-CM 306.9) 10/13/2012 (ICD-10-CM I25.119); Coronary artery disease 05/21/2021 (SNOMED CT 53741008) S/p 4v CABG 2015 (ICD-10-CM I10.); Benign essential hypertension 12/09/2015 (SNOMED CT 1201005) (ICD-10-CM I42.9); Cardiomyopathy (SNOMED CT 05/21/2021 85898001) EF 35% ECHO 05/17/21 (ICD-10-CM K21.9); Gastroesophageal reflux 12/09/2015 disease without esophagitis (SNOMED CT 266435005) Pt had received covid vaccines on 5/19/21 & 7/8/21. Likely pt's death is not related to covid vaccines given pt's advanced age, comorbidies, and long length of time between death & date of vaccine administrations.
High fever of 103 degrees; Had the chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (High fever of 103 degrees) and CHILLS (Had the chills) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PYREXIA (High fever of 103 degrees) and CHILLS (Had the chills). At the time of the report, PYREXIA (High fever of 103 degrees) and CHILLS (Had the chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Pyrexia: 103 degree (plane angle) (High) 103 degrees.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was vaccinated on 3Feb2021. On 4Feb2021 he had high fever of 103 degrees. Also he had chills.
Fever, Chills, Shortness of breath, chest pain, fatigue, and body pain.  The treatment was an inhaler of albuterol, and a week long course of steroid that I cannot remember the name of.